Picture of Aprea Therapeutics logo

APRE — Aprea Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Aprea Therapeutics Recieves Nasdaq Approved Application To Transfer Listing

July 5 (Reuters) - Aprea Therapeutics Inc  APRE.O :
    * APREA THERAPEUTICS: ON JULY 3, NASDAQ APPROVED APPLICATION
TO
TRANSFER LISTING OF COMMON STOCK FROM NASDAQ GLOBAL SELECT
MARKET TO NASDAQ CAPITAL MARKET

Source text for Eikon:  ID: 
Further company coverage:  APRE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aprea Therapeutics

See all news